|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | HPLC analysis of diverse grape and wine phenolics using direct injection and multidetection by DAD and fluorescence显示文摘 | SERGIO G A ESTEBAN G R ISIDRO H G | 2007 | Journal of Food Composition and Analysis2007，20，7： | 1 |
| 2 | Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy显示文摘 | Kevin J Martin Klaus Olgaard Jack W Coburn Giorgio M Coen Masafumi Fukagawa Craig Langman Hartmut H Malluche James T McCarthy Shaul G Massry Otto Mehls Isidro B Salusky Justin M Silver Miroslaw T Smogorzewski Eduardo M Slatopolsky Linda McCann | 2004 | American Journal of Kidney Diseases2004，，3： | 1 |
| 3 | Phenolic composition and magnitude of copigmentation in young and shortly aged red wines made from the cultivars,Cabernet Sauvignon,Cencibel,and Syrah显示文摘 | Isidro H G | 2005 | J Food Chem2005，92，： | 1 |
| 4 | P73 expression in neuroblastoma: a role in the biology of advanced tumors? 显示文摘 | Matos P Isidro G Vieira E | 2001 | Pediatr Hematol Oncol2001，18，1： | 1 |
| 5 | Short term follow-up results in 795 nonpalpable probably benign lesions detected at screening mammography显示文摘 | Isidro VM Leopoido G Luis A | 2001 | Radiology2001，219，2： | 1 |
| 6 | HPLC analysis of diverse grape and wine phenolics using direct injection and multidetection by DAD and fluorescence显示文摘 | Sergio G A Esteban G R Isidro H G | 2007 | Journal of Food Composition and Analysis2007，20，： | 1 |
| 7 | Botrydial is produced in plant tissues infected by Botrytis cinerea显示文摘 | Nigel Deighton Ingo Muckenschnabel Ana J Colmenares Isidro G Collado Brian Williamson | 2001 | Phytochemistry2001，，5： | 1 |
| 8 | Acetophenones and terpenoids from Senecio gallicus 显示文摘 | Julio G U J De Pascual T Isidro S M | 1987 | Phytochemistry1987，26，4： | 1 |
| 9 | Phenolic composition and magnitude of copigmentation in young and shortly aged red wines made from the cultivars, Cabernet Sauvignon, Cencibel, and Syrah 显示文摘 | Isidro H G Lorenzo E Almudena V | 2005 | Food Chemistry2005，92，： | 1 |
| 10 | Germline MUTYH(MYH) mutations in portuguese individuals with multiple colorectal adenomas显示文摘 | ISIDRO G LARANJEIRA F PIRES A | 2004 | Hum Mutat2004，24，4： | 1 |
| 11 | Phenolic composition and magnitude of copigmentation in young and shortly aged red wines made from the cultivars, Cabemet Sauvignon, Cencibel, and Syrah显示文摘 | ISIDRO HERMOSIN G | 2005 | Food Chemistry2005，，92： | 1 |
| 12 | Novel MLH1 mutations and a novel MSH2 polymorphism identified by SSCP and DHPLC in Portuguese HNPCC families显示文摘 | Isidro G Matos S Goncalves V | 2003 | Hum Mutat2003，22，5： | 1 |
| 13 | Secondary mctabolites from species of the biocontrol agent Trichoderma显示文摘 | Jose Luis Rcino R F G Rosario H G Isidro G C | 2008 | Phytochemistry Reviews2008，7，1： | 1 |
| 14 | Biotransformations by colletotrichum species 显示文摘 | Garcar-pajon C M Hernandez-galan R Isidro G C | 2003 | Tetrahedron: Asymmertry2003，14，10： | 1 |
| 15 | Biotransformations by Colletotrichum species显示文摘 | C M García-Pajo' n R Herna' ndez-Gala' n Isidro G Collado | 2003 | Tetrahedron:Asymmetry2003，14，： | 1 |
| 16 | Novel MLH1 mutations and a novel MSH2 polymorphism identified by SSCP and DHPLC in Portuguese HNPCC families显示文摘 | Isidro G Matos S Goncalves V | 2003 | Hum Mutat2003，22，5： | 1 |
| 17 | p73 expression in neuroblastoma:a role in the biology of advanced tumors 显示文摘 | Isidro G Lacerda AF | 2001 | Pediatr Hematol Oncol2001，18，1： | 1 |
| 18 | Interferon-free treatments in patients with hepatitis C genotype 1-4 infections in a real-world setting显示文摘AIM To investigated the real-world effectiveness and safety of various regimens of interferon-free treatments in patients infected with hepatitis C virus(HCV).METHODS We performed an observational study to analyze different antiviral treatments administered to 462 HCV-infected patients, of which 56.7% had liver cirrhosis. HCV RNA after 4 wk of treatment and at 12 wk after treatment sustained virologic response(SVR) as well as serious adverse events(SAEs) was analyzed first for the whole cohort and then separately in patients who met or did not meet the inclusion criteria of a clinical trial(CT-met and CT-unmet, respectively).RESULTS The most frequently prescribed treatment was simeprevir/sofosbuvir(36.4%), followed by sofosbuvir/ledipasvir(24.9%) and ombitasvir/paritaprevir/ritonavir(r)/dasabuvir(19.9%). Ribavirin(RBV) was administered in 198 patients(42.9%). SVRs occurred in 437/462 patients(94.6%). The SVRs ranged between 93.3% and 100% for genotypes 1-4. SVRs were achieved in 96.2% patients in the CTmet group vs 91.9% patients in the CT-unmet group(P = 0.049). Undetectable HCV RNA at week 4 occurred in 72.9% of the patients. In the univariate analysis, the factors associated with SVRs were lower liver stiffness, absence of cirrhosis, higher platelet count, higher albumin levels, no RBV dose reduction, undetectable HCV RNA at week 4 and CT-met group. In the multivariate analysis, only albumin was an independent predictor of treatment failure(P = 0.04). Eleven patients(2.4%) developed SAEs; 5.2% and 0.7% of the patients in the CT-unmet and CT-met groups, respectively(P = 0.003).CONCLUSION A high proportion of patients with HCV infection achieved SVRs. For patients who did not meet the CT criteria, treatment regimens must be optimized. | Huascar Ramos Pedro Linares Ester Badia Isabel Martín Judith Gómez Carolina Almohalla Francisco Jorquera Sara Calvo Isidro García Pilar Conde Begona álvarez Guillermo Karpman Sara Lorenzo Visitación Gozalo Mónica Vásquez Diana Joao Marina de Benito Lourdes Ruiz Felipe Jiménez Federico Sáez-Royuela 无 | 2017 | World Journal of Gastrointestinal Pharmacology and Therapeutics2017，8，2： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员